GB2380129B - Pharmaceutical formulations - Google Patents
Pharmaceutical formulationsInfo
- Publication number
- GB2380129B GB2380129B GB0203527A GB0203527A GB2380129B GB 2380129 B GB2380129 B GB 2380129B GB 0203527 A GB0203527 A GB 0203527A GB 0203527 A GB0203527 A GB 0203527A GB 2380129 B GB2380129 B GB 2380129B
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0103638A GB0103638D0 (en) | 2001-02-14 | 2001-02-14 | Pharmaceutical formulations |
US28004401P | 2001-03-30 | 2001-03-30 | |
US09/827,158 US6730330B2 (en) | 2001-02-14 | 2001-04-05 | Pharmaceutical formulations |
GB0111597A GB2377633A (en) | 2001-05-11 | 2001-05-11 | Pharmaceutical compositions comprising the cannabinoids THC and CBD |
GB0121715A GB2381194A (en) | 2001-09-07 | 2001-09-07 | Pharmaceutical formulations |
US59102201A | 2001-09-12 | 2001-09-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0203527D0 GB0203527D0 (en) | 2002-04-03 |
GB2380129A GB2380129A (en) | 2003-04-02 |
GB2380129B true GB2380129B (en) | 2004-08-11 |
Family
ID=27546616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0203527A Expired - Lifetime GB2380129B (en) | 2001-02-14 | 2002-02-14 | Pharmaceutical formulations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2380129B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9168278B2 (en) | 2004-11-16 | 2015-10-27 | Gw Pharma Limited | Use for cannabinoid |
GB0425248D0 (en) * | 2004-11-16 | 2004-12-15 | Gw Pharma Ltd | New use for cannabinoid |
AU2007295179B2 (en) | 2006-09-15 | 2013-05-30 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
US9084771B2 (en) | 2007-05-17 | 2015-07-21 | Sutter West Bay Hospitals | Methods and compositions for treating cancer |
GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
GB2469792A (en) * | 2009-04-23 | 2010-11-03 | Calvin John Ross | Oil-based pharmaceutical formulation for sublingual delivery |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
AU2015292915B2 (en) * | 2014-07-21 | 2020-10-15 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal or sublingual administration of cannabinoids |
GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
GB201806953D0 (en) | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
EP3876925A4 (en) * | 2018-11-07 | 2022-08-10 | Columbia Care LLC | Sublingual and buccal dosage forms of cannabinoid extracts and method of use thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3428728A (en) * | 1965-10-21 | 1969-02-18 | Hans Lowey | Timed release sublingual medications |
WO1995005163A1 (en) * | 1993-08-13 | 1995-02-23 | Pharmos Corporation | Bioadhesive emulsion preparations for enhanced drug delivery |
US5462749A (en) * | 1991-09-25 | 1995-10-31 | Mcnell-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
WO1995034286A1 (en) * | 1994-06-15 | 1995-12-21 | Minnesota Mining And Manufacturing Company | Transmucosal delivery system |
-
2002
- 2002-02-14 GB GB0203527A patent/GB2380129B/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3428728A (en) * | 1965-10-21 | 1969-02-18 | Hans Lowey | Timed release sublingual medications |
US5462749A (en) * | 1991-09-25 | 1995-10-31 | Mcnell-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
WO1995005163A1 (en) * | 1993-08-13 | 1995-02-23 | Pharmos Corporation | Bioadhesive emulsion preparations for enhanced drug delivery |
WO1995034286A1 (en) * | 1994-06-15 | 1995-12-21 | Minnesota Mining And Manufacturing Company | Transmucosal delivery system |
Non-Patent Citations (2)
Title |
---|
Proc. 1st World Meet. Pharm., Biopharm. Pharm. Technol., 639-40, (1995) * |
Proc. 26th Int. Symp. Controlled Release Bioact. Mater., 913-914, (1999) * |
Also Published As
Publication number | Publication date |
---|---|
GB2380129A (en) | 2003-04-02 |
GB0203527D0 (en) | 2002-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0319041D0 (en) | Pharmaceutical Formulations | |
GB0102342D0 (en) | Pharmaceutical formulation | |
IL164519A0 (en) | Pharmaceutical formulations | |
HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
GB0111597D0 (en) | Pharmaceutical compositions | |
GB0118689D0 (en) | Pharmaceutical formulation | |
GB0104534D0 (en) | Pharmaceutical combination | |
PL366432A1 (en) | Pharmaceutical formulation | |
GB0121715D0 (en) | Pharmaceutical formulations | |
GB2392093B (en) | Pharmaceutical formulations | |
GB0120701D0 (en) | Pharmaceutical formulations | |
GB0103638D0 (en) | Pharmaceutical formulations | |
GB2380129B (en) | Pharmaceutical formulations | |
GB0105560D0 (en) | Pharmaceutical formulations | |
GB0124523D0 (en) | Pharmaceutical combination | |
GB0104752D0 (en) | Pharmaceutical compositions | |
GB0129270D0 (en) | Pharmaceutical combination | |
GB0129397D0 (en) | Pharmaceutical combination | |
GB2382302B (en) | Pharmaceutical compositions | |
GB0124455D0 (en) | Pharmaceutical formulations | |
GB0129395D0 (en) | Pharmaceutical combination | |
GB0104749D0 (en) | Pharmaceutical formulation | |
GB0115893D0 (en) | Formulations | |
GB0101966D0 (en) | Pharmaceutical formulations | |
GB0118299D0 (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Expiry date: 20220213 |